When fiber reaches your colon, gut bacteria ferment it into short-chain fatty acids, which directly stimulate the L-cells to release GLP-1
P = 0.01) 119
Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time
When this analysis was repeated using only adjudicated trials, the results were left unchanged (OR 1.00
Retatrutide demonstrates clear clinical efficacy in obesity management based on current trial evidence
Introduction Chronic diseases including autoimmune diseases, cancer, cardiovascular diseases, diabetes, hepatocellular, neurological, and renal diseases have persistent high incidence and fatality rates worldwide